Monday, September 21, 2026
Invest Strategies Group
  • Investing
  • Economy
  • Business
  • Stock
No Result
View All Result
Invest Strategies Group
  • Investing
  • Economy
  • Business
  • Stock
No Result
View All Result
Invest Strategies Group
No Result
View All Result
Home Business

Pepsi sued by federal regulators for giving Walmart preferential soft-drink pricing

admin by admin
January 18, 2025
in Business
0
Pepsi sued by federal regulators for giving Walmart preferential soft-drink pricing
0
SHARES
13
VIEWS
Share on FacebookShare on Twitter

The Federal Trade Commission said Friday that it is suing PepsiCo for illegal price discrimination, alleging the food and beverage giant gave an unnamed retailer more favorable prices than its competition.

Walmart is the unnamed retailer, people familiar with the matter told CNBC.

The FTC alleges Pepsi violated the Robinson-Patman Act, which bars sellers from giving competing buyers different prices for the same “commodity” or selectively providing allowances, like compensation for advertising. The agency argues Pepsi gave Walmart promotional payments and allowances, as well as advertising and promotional tools, that it didn’t offer to the retail giant’s rivals.

Pepsi denied the allegations and said the FTC’s lawsuit is wrong, both factually and legally.

“PepsiCo strongly disputes the FTC’s allegations, and the partisan manner in which the suit was filed. We will vigorously present our case in court,” the company said in a statement to CNBC. “PepsiCo’s practices are in line with industry norms and we do not favor certain customers by offering discounts or promotional support to some customers and not others.”

Walmart did not immediately respond to a request for comment from CNBC.

The complaint, which was filed in the Southern District of New York, is currently sealed.

The FTC also said that a “substantial portion” of the alleged violations are redacted in the lawsuit, citing legal protections given to Pepsi and the large, big box retailer. The commission is seeking to lift the redactions to show how Pepsi broke the law and how those alleged actions led to higher prices for competing retailers.

The Robinson-Patman Act was passed in 1936, but the federal government stopped enforcing it during the deregulation of the 1980s. The FTC resumed its enforcement in December when it sued Southern Glazer’s, the largest U.S. distributor of wine and spirits.

The lawsuit comes on the final business day before President-elect Donald Trump’s inauguration on Monday, which will spell the end of Lina Khan’s time as chair of the FTC. Her Republican successor, Andrew Ferguson, currently serves on the commission and released a statement dissenting against the decision to sue Pepsi.

The Biden administration has taken a flurry of legal action against companies and corporate executives in its final days, targeting Capital One, Southwest Airlines and Elon Musk, among others.

— CNBC’s Mary Catherine Wellons contributed reporting for this story.

This post appeared first on NBC NEWS

Previous Post

UnitedHealth CEO says U.S. health system ‘needs to function better’

Next Post

Vanguard fined more than $100 million by SEC over violations involving target date retirement funds

admin

admin

Next Post
S&P 500 climbed 0.3%, and Nasdaq-100 futures  jumped 0.7%

S&P 500 climbed 0.3%, and Nasdaq-100 futures jumped 0.7%

    Subscribe to our newsletter for early access to new products, exclusive deals, and exciting updates. Don't miss out! Our subscribers are always the first to hear about limited-time offers and new arrivals. Plus, you'll get sneak peeks and bonus content that adds value to your experience.


    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    Recommended

    Brunswick Exploration

    Brunswick Exploration

    June 19, 2025
    InMed Announces Successful Completion of Pharmacokinetic Studies in Large Animal Model for Its Alzheimer’s Disease Candidate INM-901

    InMed Announces Successful Completion of Pharmacokinetic Studies in Large Animal Model for Its Alzheimer’s Disease Candidate INM-901

    November 18, 2025

    Recent News

    Blaize (BZAI) Q2 2026 Earnings Call Transcript

    3 Reasons CRISPR Therapeutics Stock Is Still a Buy After a Rocky 2026

    September 20, 2026
    The House | Angus MacDonald: "If You're Active In Faith, You're More Likely To Have A Moral Compass"

    The House | Angus MacDonald: “If You’re Active In Faith, You’re More Likely To Have A Moral Compass”

    September 20, 2026
    AMC Robotics Secures Up to $50M Equity Facility to Fund Robot Manufacturing Plant

    AMC Robotics Secures Up to $50M Equity Facility to Fund Robot Manufacturing Plant

    September 20, 2026
    Blaize (BZAI) Q2 2026 Earnings Call Transcript

    Buying This Hidden Software Stock Might Just Give You Massive Exposure to the Anthropic IPO

    September 20, 2026
    Invest Strategies Group

    Browse by Category

    • Business
    • Economy
    • Investing
    • Stock

    Recent News

    Blaize (BZAI) Q2 2026 Earnings Call Transcript

    3 Reasons CRISPR Therapeutics Stock Is Still a Buy After a Rocky 2026

    September 20, 2026
    The House | Angus MacDonald: "If You're Active In Faith, You're More Likely To Have A Moral Compass"

    The House | Angus MacDonald: “If You’re Active In Faith, You’re More Likely To Have A Moral Compass”

    September 20, 2026
    • Terms & Conditions
    • Privacy Policy

    Copyright © 2026 investstrategiesgroup.com | All Rights Reserved

    No Result
    View All Result
    • Home 1
    • Privacy Policy
    • Terms & Conditions
    • Thank you

    Copyright © 2026 investstrategiesgroup.com | All Rights Reserved